Xtant Medical Holdings, Inc. (XTNT) — Analysis Summary
Xtant Medical Holdings, Inc. (XTNT) has a market cap of $60.29M with year-over-year revenue growth of +14.2%. Net margin stands at 3.7%. The stock trades at a P/E ratio of 33.0.
Key Takeaways
- Revenue changed +14.2% year-over-year
- Net margin of 3.7%
- P/E ratio of 33.0
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, XTNT posted revenue growth of +14.2% and trades at a P/E of 33.0.
Xtant Medical Holdings, Inc. (XTNT)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at 1.0x — minimal debt service cushion
Net income fell 63.3% vs the prior period.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
151
Headquarters
BELGRADE, MT
Exchange
XASE
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.